Scientists track blood clues to improve hepatitis d treatment
NCT ID NCT07313358
Summary
This study aims to learn more about how patients with chronic hepatitis D (HDV) respond to a treatment called bulevirtide (BLV). Researchers will analyze existing and future blood samples from about 220 patients to see how their virus levels change over time. The main goal is to find patterns in the blood that can predict which patients are most likely to benefit from the treatment and to compare the accuracy of different lab tests used to measure the virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HDV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Heinrich Heine University
Düsseldorf, Germany, 40225, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Università di Milano
Milan, Italy, 20122, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.